The Role of Vascular Endothelial Growth Factor in the Tissue Specific in Vivo Growth of Prostate Cancer Cells

References

• Auerbach R. Patterns of tumor metastasis: organ selectivity in the spread of cancer cells. Lab. Invest. 1988; 58(4)361–364
   PubMedGoogle Scholar
• Balbay M. D, Pettaway C. A, Kuniyasu H., Inoue K., Ramirez E., Li E., Fidler I. J, Dinney C. P. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin. Cancer Res. 1999; 5(4)783–789
   PubMedGoogle Scholar
• Brown T., Mackey K. Analysis of RNA by Northern and Slot Blot Hybridization. Current Protocols in Molecular Biology, F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Sedman, J. A. Smith, K. Struhl. John Wiley & Sons, New York 1997; 4.9.1–4.9.16.
   Google Scholar
• Cheng S. Y, Huang H. J, Nagane M., Ji X. D, Wang D., Shih C. C, Arap W., Huang C. M, Cavenee W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. U.S.A. 1996; 93(16)8502–8507
   PubMed Web of Science ®Google Scholar
• Chung L. W. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv. 1995; 23: 33–42
   PubMedGoogle Scholar
• Connolly J. M, Rose D. P. Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J. Urol. 1998; 160(3 Pt 1)932–936
   PubMedGoogle Scholar
• Fabra A., Nakajima M., Bucana C. D, Fidler I. J. Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation 1992; 52(1)101–110
   PubMedGoogle Scholar
• Fidler I. J. Critical factors in the biology of human cancer metastasis. Am. Surg. 1995; 61(12)1065–1066
   PubMedGoogle Scholar
• Folkman J. Angiogenesis and angiogenesis inhibition: an overview. Exs. 1997; 79: 1–8
   PubMedGoogle Scholar
• Fort M. M, Leach M. W, Rennick D. M. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J. Immunol. 1998; 161(7)3256–3261
   PubMedGoogle Scholar
• Fukumura D., Xavier R., Sugiura T., Chen Y., Park E. C, Lu N., Selig M., Nielsen G., Taksir T., Jain R. K, Seed B. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998; 94(6)715–725
   PubMed Web of Science ®Google Scholar
• Gaffey M. J, Frierson H. F, Weiss L. M, Barber C. M, Baber G. B, Stoler M. H. Human papillomavirus and Epstein-Barr virus in sinonasal Schneiderian papillomas. An in situ hybridization and polymerase chain reaction study. Am. J. Clin. Pathol. 1996; 106(4)475–482
   PubMedGoogle Scholar
• Gallagher S. R. One-Dimensional SDS Gel Electrophoresis of Proteins. Current Protocols in Molecular Biology, F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Sedman, J. A. Smith, K. Struhl. John Wiley & Sons, New York 1999; 10.12A.14–10.12A.19
   Google Scholar
• Gallagher S. R, Winston S. E, Fuller S. A, Hurrell J. G.R. Immunoblotting and Immunodetection. Current Protocols in Molecular Biology, F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Sedman, J. A. Smith, K. Struhl. John Wiley & Sons, New York 1997; 10.18.11–10.18.21
   Google Scholar
• Gleave M., Hsieh J. T, Gao C. A., von Eschenbach A. C, Chung L. W. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991; 51(14)3753–3761
   PubMedGoogle Scholar
• Gopas J., Rager-Zisman B., Bar-Eli M., Hammerling G. J., Segal S. The relationship between MHC antigen expression and metastasis. Adv. Cancer Res. 1989; 53: 89–115
   PubMedGoogle Scholar
• Grant D. S, Rose R. W, Kinsella J. K, Kibbey M. C. Angiogenesis as a component of epithelial-mesenchymal interactions. Exs. 1995; 74: 235–248
   PubMedGoogle Scholar
• Harper M. E., Glynne-Jones E., Goddard L., Mathews P., Nicholson R. I. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. J. Pathol. 1998; 186(2)169–177
   PubMedGoogle Scholar
• Hayward S. W, Grossfeld G. D, Tlsty T. D, Cunha G. R. Genetic and epigenetic influences in prostatic carcino-genesis (review). Int. J. Oncol. 1998; 13(1)35–47
   PubMedGoogle Scholar
• Huggins C. B. Commentary on the treatment of prostate cancer. J. Urol. 1969; 102(2)119–120
   PubMedGoogle Scholar
• Ito Y., Iwamoto Y., Tanaka K., Okuyama K., Sugioka Y. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int. J. Cancer 1996; 67(1)148–152
   PubMedGoogle Scholar
• Luzzi K. J., MacDonald I. C, Schmidt E. E, Kerkvliet N., Morris V. L, Chambers A. F, Groom A. C. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 1998; 153(3)865–873
   PubMed Web of Science ®Google Scholar
• Melnyk O., Zimmerman M., Kim K. J., Shuman M. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. J. Urol. 1999; 161(3)960–963
   PubMed Web of Science ®Google Scholar
• Nichols G. E, Williams M. E, Gaffey M. J, Stoler M. H. Cyclin D1 gene expression in human cervical neoplasia. Mod. Pathol. 1996; 9(4)418–425
   PubMedGoogle Scholar
• Pan L., Teshima T., Hill G. R, Bungard D., Brinson Y. S, Reddy V. S, Cooke K. R, Ferrara J. L. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999; 93(12)4071–4078
   PubMed Web of Science ®Google Scholar
• Pettaway C. A, Pathak S., Greene G., Ramirez E., Wilson M. R, Killion J. J, Fidler I. J. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res. 1996; 2(9)1627–1636
   PubMed Web of Science ®Google Scholar
• Sato N., Gleave M. E, Bruchovsky N., Rennie P. S, Beraldi E., Sullivan L. D. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res. 1997; 57(8)1584–1589
   PubMedGoogle Scholar
• Sheta E. A, Harding M. A, Conaway M. R, Theodorescu D. Focal Adhesion Kinase, Rapl, and Transcriptional Induction of Vascular Endothelial Growth Factor. J. Natl. Cancer Inst. 2000; 92(13)1065–1073
   PubMedGoogle Scholar
• Theodorescu D., Broder S. R, Boyd J. C, Mills S. E., Frierson H. F., Jr. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 1997; 80(11)2109–2119
   PubMedGoogle Scholar
• Theodorescu D., Cornil L, Fernandez B. J, Kerbel R. S. Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1990; 87(22)9047–9051
   PubMedGoogle Scholar
• Theodorescu D., Laderoute K. R, Guiding K. M. Epidermal Growth Factor Receptor-Regulated Human Bladder Cancer Motility Is in Part a Phosphatidylinositol 3-Kinase-Mediated Process. Cell Growth Differ. 1998; 9(11)919–928
   PubMedGoogle Scholar
• Vukicevic S., Kleinman H. K, Luyten P. P, Roberts A. B, Roche N. S, Reddi A. H. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp. Cell Res. 1992; 202(1)1–8
   PubMed Web of Science ®Google Scholar
• Wu H. C, Hsieh J. T, Gleave M. E, Brown N. M, Pathak S., Chung L. W. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer 1994; 57(3)406–412
   PubMed Web of Science ®Google Scholar
• Wu T. T, Sikes R. A, Cui Q., Thalmann G. N, Kao C., Murphy C. F, Yang H., Zhau H. E, Balian G., Chung L. W. Establishing human prostate cancer cell xeno-grafts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int. J. Cancer 1998; 77(6)887–894
   PubMedGoogle Scholar